IIPR - Innovative Industri... Stock Analysis | Stock Taper
Logo
Innovative Industrial Properties, Inc.

IIPR

Innovative Industrial Properties, Inc. NYSE
$52.96 -3.04% (-1.66)

Market Cap $1.49 B
52w High $74.92
52w Low $44.58
Dividend Yield 14.07%
Frequency Quarterly
P/E 13.48
Volume 390.05K
Outstanding Shares 28.14M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $66.66M $-10.57M $31.84M 47.77% $1.07 $57.1M
Q3-2025 $64.69M $27.32M $29.3M 45.3% $1.01 $52.47M
Q2-2025 $62.89M $27.13M $26.02M 41.38% $0.87 $48.97M
Q1-2025 $71.72M $30.38M $31.08M 43.33% $1.05 $53.97M
Q4-2024 $76.74M $27.13M $40.02M 52.15% $1.38 $61.38M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $47.6M $2.37B $522.85M $1.85B
Q3-2025 $36.67M $2.34B $474.57M $1.86B
Q2-2025 $99.67M $2.31B $424.65M $1.88B
Q1-2025 $128.01M $2.35B $430.42M $1.92B
Q4-2024 $146.25M $2.38B $441.99M $1.94B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $31.84M $49.91M $-41.73M $2.74M $10.93M $49.91M
Q3-2025 $29.3M $45.59M $-109.66M $1.08M $-62.99M $45.59M
Q2-2025 $26.02M $48.45M $-5.76M $-71.04M $-28.34M $48.45M
Q1-2025 $31.08M $54.24M $-17.16M $-55.32M $-18.23M $54.24M
Q4-2024 $39.45M $58.07M $-3.56M $-55.38M $-883K $40.63M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Innovative Industrial Properties, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Across the financials, IIPR shows a combination of high profitability, strong cash generation, and a very conservative balance sheet with no debt and ample liquidity. Its business model—long‑term, triple‑net leases on specialized properties—naturally supports high margins and predictable cash flows when tenants are healthy. The company’s first‑mover position in cannabis real estate, specialized underwriting capabilities, and growing experience in similar niches like life sciences real estate further support its strategic positioning. Generous dividend payments reflect confidence in the stability of its current cash flows and make it a clearly income‑oriented platform.

! Risks

The biggest risks stem from concentration in a single, still‑nascent industry and a strategy that emphasizes distributions over reinvestment. Tenant financial stress, regulatory uncertainty, and evolving competition can impact rent collections and property values. Specialized cannabis facilities may be challenging to re‑lease or repurpose if a tenant fails, raising potential vacancy or capital spending needs. The absence of retained earnings and the reliance on high payout ratios mean there is less internally generated capital available for future growth or to cushion prolonged downturns, despite today’s strong liquidity. Limited historical data in the snapshot also makes it harder to judge how the company performs through a full cycle of industry stress.

Outlook

Looking ahead, IIPR appears well positioned financially to navigate industry volatility, thanks to its strong margins, net cash balance, and sizable free cash flow. If the cannabis sector stabilizes and potential regulatory tailwinds materialize, tenant health could improve and create new growth opportunities for sale‑leaseback deals. At the same time, the company’s move into life sciences real estate suggests an awareness of concentration risk and a desire to build additional growth engines. The overall outlook is balanced: the current portfolio supports solid income characteristics, but long‑term performance will depend on how effectively IIPR manages tenant risk, maintains its competitive edge, and reallocates capital between dividends, new investments, and diversification initiatives.